![Powell Industries, Inc.](/common/images/company/TG_PW2.png)
Presentation to highlight statistically significant Phase 3 results of Tonmya™ for the management of fibromyalgia, including improvement in pain and sleep quality Tonix granted FDA Fast Track...
Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill an unmet medical need Fast Track designation for Tonmya recognizes fibromyalgia as a...
CHATHAM, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced the...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 24.7 | 18.9562547966 | 130.3 | 155.5 | 120 | 290 | 125.97638049 | DE |
4 | 20.1 | 14.899925871 | 134.9 | 155.5 | 119.2 | 140 | 127.04344795 | DE |
12 | 7.30001 | 4.94245801912 | 147.69999 | 195 | 119.2 | 244 | 150.11334077 | DE |
26 | 67.5 | 77.1428571429 | 87.5 | 195 | 87.5 | 242 | 145.21046182 | DE |
52 | 76.5 | 97.4522292994 | 78.5 | 195 | 68.5 | 201 | 132.86255687 | DE |
156 | 76.5 | 97.4522292994 | 78.5 | 195 | 68.5 | 201 | 132.86255687 | DE |
260 | 76.5 | 97.4522292994 | 78.5 | 195 | 68.5 | 201 | 132.86255687 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관